{"Clinical Trial ID": "NCT04030104", "Intervention": ["INTERVENTION 1:", "IUS Alone", "IUS alone imaging", "INTERVENTION 2:", "Imagio (IUS+OA)", "IUS+OA imaging"], "Eligibility": ["Incorporation criteria:", "- An analyzable mass per patient: BI-RADS 3 and 4a, 4b, 4c and 5 mass declared by the clinical investigator through the criteria for inclusion of the PIONEER study and classified as BIRADS 3, 4a, 4b 4c and 5 by conventional diagnostic ultrasound (CDU)", "Reported masses in PIONEER population Intention to Diagnose (ITD)/Analysis, including high risk cases by original PIONEER protocol", "Age of the patient, indication for entry into the study and medical history available", "The evaluable mammograms and the OA and IUS video loops and the stills for each mass", "- Exclusion criteria:", "There is a lack of images and/or video loops or motionless and incorrect IUS or OA video loops that would prevent a case from being evaluated by the players.", "Reviewer-02 Competency Test and Training Cases"], "Results": ["Performance measures:", "\u2022 Increased specificity at 98% fixed sensitivity (fSp)", "The main efficacy criterion was the difference (gain) in specificity (fSp) at a fixed sensitivity of 98% for IMS+OA versus IUS alone, of the 15 independent readers; the two imaging methods used for each subject (subject as own control); the results for each imaging modality compared to the biopsy diagnosis or the 12-month benign follow-up decision according to the truth panel (ground truth).", "Time frame: 12-month baseline +/- 30 follow-up days", "Results 1:", "Title of arm/group: IUS Alone", "Description of the arm/group: IUS Imagery alone", "Total number of participants analysed: 480", "Average (95% confidence interval)", "Unit of measure: % benign masses+TPB correctly identified 38.22 (24.85 to 51.59)", "Results 2:", "Title of the arm/group: Imagio (IUS+OA)", "Description of the arm/group: IUS+OA Imagery", "Total number of participants analysed: 480", "Average (95% confidence interval)", "Unit of measure: % benign masses+TPB correctly identified 47.20 (35.91 to 58.49)"], "Adverse Events": ["Undesirable Events 1:", "Total: 2/480 (0.42%)", "1/480 (0.21%)", "Lung cancer [2]1/480 (0.21%)", "Adverse Events 2:", "- Yeah, that's right."]}